ID: ALA2070516

Max Phase: Preclinical

Molecular Formula: C22H35N2O11P

Molecular Weight: 534.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC[C@H](NP(=O)(Oc1ccc(OC)cc1)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O)C(=O)OCC

Standard InChI:  InChI=1S/C22H35N2O11P/c1-5-7-16(21(28)32-6-2)24-36(30,34-15-10-8-14(31-4)9-11-15)35-20-18(23-13(3)26)22(29)33-17(12-25)19(20)27/h8-11,16-20,22,25,27,29H,5-7,12H2,1-4H3,(H,23,26)(H,24,30)/t16-,17+,18+,19+,20+,22-,36?/m0/s1

Standard InChI Key:  VPYJWWUBPMGMPY-HWOJWQIHSA-N

Associated Targets(non-human)

Cartilage 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 534.50Molecular Weight (Monoisotopic): 534.1978AlogP: 0.46#Rotatable Bonds: 13
Polar Surface Area: 182.11Molecular Species: NEUTRALHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.20CX Basic pKa: CX LogP: -0.30CX LogD: -0.30
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.17Np Likeness Score: 0.73

References

1. Serpi M, Bibbo R, Rat S, Roberts H, Hughes C, Caterson B, Alcaraz MJ, Gibert AT, Verson CR, McGuigan C..  (2012)  Novel phosphoramidate prodrugs of N-acetyl-(D)-glucosamine with antidegenerative activity on bovine and human cartilage explants.,  55  (10): [PMID:22501024] [10.1021/jm300074y]

Source